p53 and bcl-2 Expression in High-Grade B-Cell Lymphomas
Author Information
Author(s): M.A. Piris, F. Pezella, J.C. Martinez-Montero, J.L. Orradre, R. Villuendas, M. Sanchez-Beato, R. Cuena, M.A. Cruz, B. Martinez, M.C. Garrido, K. Gatter, A. Aiello, D. Delia, R. Giardini, F. Rilke
Primary Institution: Hospital Virgen de la Salud, Toledo, Spain
Hypothesis
The study investigates the relationship between bcl-2 and p53 expression and survival probability in patients with B-cell high-grade lymphoma.
Conclusion
p53 expression is significantly related to survival probability, indicating a poor prognosis, while bcl-2 expression does not show a significant correlation with overall survival.
Supporting Evidence
- p53-positive patients showed a sudden decrease in life expectancy in the first months after diagnosis.
- Simultaneous expression of bcl-2 and p53 was associated with a poorer prognosis than p53 alone.
- Statistical analysis confirmed that p53 expression indicates a poor prognosis.
Takeaway
This study looked at how two proteins, p53 and bcl-2, affect how long people with a certain type of cancer live. It found that p53 is important for predicting survival.
Methodology
The study analyzed tissue samples from 119 patients using immunohistochemistry to assess bcl-2 and p53 protein expression and their correlation with survival.
Limitations
The study did not analyze MALT and Burkitt lymphomas separately due to small sample sizes.
Participant Demographics
Patients were from Spain, the UK, and Italy, treated with chemo- and/or radiotherapy.
Statistical Information
P-Value
0.0125
Confidence Interval
1.15-3.97
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website